ESC 365 - Advances in hyperkalaemia management – overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.

Open Access

Advances in hyperkalaemia management – overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.

Session: Co-morbidities in chronic heart failure – time for paradigm shifts in the management of hyperkalaemia and iron deficiency

Topic: Chronic Heart Failure

Speaker: Professor I. Pina (Philadelphia, US)

Organised by Charité supported with an educational grant from Vifor

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Ileana Pina

Thomas Jefferson University, Philadelphia (United States of America)

43 presentations

2 followers

3 more presentations in this session

Hyperkalaemia and iron deficiency in chronic heart failure – how important?

Speaker: Professor S. Anker (Berlin, DE)

Iron deficiency management – impact on clinically important outcomes.

Speaker: Professor P. Van Der Meer (Groningen, NL)

Panel discussion and close - Hyperkalaemia and iron deficiency: time for a paradigm change.

Speaker: Professor I. Pina (Philadelphia, US) Professor G. Filippatos (Athens, GR) Professor J. Butler (Dallas, US) Professor P. Van Der Meer (Groningen, NL) Professor S. Anker (Berlin, DE)

Access the full session

Co-morbidities in chronic heart failure – time for paradigm shifts in the management of hyperkalaemia and iron deficiency

Speakers: Professor I. Pina, Professor S. Anker, Professor P. Van Der Meer, Professor I. Pina, Professor G. Filippatos...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources